The average one-year price target for Aurobindo Pharma INR1 (NSE:AUROPHARMA) has been revised to 869.61 / share. This is an increase of 26.48% from the prior estimate of 687.53 dated August 1, 2023. The price target is an average of many targets provided by analysts. The latestThe average one-year price target for Aurobindo Pharma INR1 (NSE:AUROPHARMA) has been revised to 869.61 / share. This is an increase of 26.48% from the prior estimate of 687.53 dated August 1, 2023. The price target is an average of many targets provided by analysts. The latest